Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
@article{APM86930, author = {Jinfei Si and Xiaodong Gu and Wenxian Wang and Shenpeng Ying and Zhengbo Song}, title = {Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)}, journal = {Annals of Palliative Medicine}, volume = {11}, number = {5}, year = {2021}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/86930} }